Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Singapore Institute of Advanced Medicine Holdings Ltd. ( (SG:9G2) ).
Singapore Institute of Advanced Medicine Holdings Ltd. has announced an update regarding its loan agreement with Caterine Limited. The lender has agreed to extend the maturity date of the S$5,000,000 loan to December 13, 2025. This extension provides the company with additional time to manage its financial obligations, potentially impacting its operational flexibility and financial strategy.
More about Singapore Institute of Advanced Medicine Holdings Ltd.
Singapore Institute of Advanced Medicine Holdings Ltd. operates in the healthcare industry, focusing on advanced medical services and technologies. The company was listed on the Catalist of the Singapore Exchange Securities Trading Limited in February 2024, with its initial public offering sponsored by PrimePartners Corporate Finance Pte. Ltd.
YTD Price Performance: -21.67%
Average Trading Volume: 89,850
Technical Sentiment Consensus Rating: Strong Buy
For an in-depth examination of 9G2 stock, go to TipRanks’ Stock Analysis page.